FDA: Draft Guidance For Laboratory-Developed Test Regs Taking Extra Time
This article was originally published in The Gray Sheet
Executive Summary
The head of FDA’s diagnostics office is hopeful that draft guidance governing laboratory-developed tests will be issued by year-end, but cautioned that the process is taking more time than expected.
You may also be interested in...
FDA Subject To More Oversight Following User Fee Bill Passage
The legislation, awaiting the signature of the president, will bring greater scrutiny of device center activities by Congress and industry.
FDA Agrees To Waive User Fees For Reviews Of Lab-Developed Tests
Although FDA is still developing its lab-developed test regulatory framework, it has agreed not to collect user fees to support its planned review of the tests.
Views Differ On How Lab-Developed Tests Fit In FDA Companion Dx Guidance
Laboratory-developed tests are not explicitly mentioned in FDA’s 12-page draft guidance on companion diagnostics issued this summer, but the issue attracted significant attention in written comments in response to the document.